NOVEL 2013 EUROPEAN SOCIETY OF HYPERTENSION AND EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION: LONG-EXPECTED ANSWERS AND NEW QUESTIONS ArticleKobalava Russian Z.D.Arterial Hypertension. Vol. 20. 2014. P.. 19-26
OPTIMIZATION OF ARTERIAL HYPERTENSION MANAGEMENT BY THE USE OF TWO- AND THREE-DRUGS FIXED DOSE COMBINATIONS AT THE DAILY STAY DEPARTMENT ArticleКОБАЛАВА Ж.Д., КОТОВСКАЯ Ю.В., ЛОБЖАНИДЗЕ Т.В., КРАВЦОВА О.А.Kardiologiia. Vol. 54. 2014. P.. 17-24
MODULATING EFFECT OF TARGET BLOOD PRESSURE ACHIEVEMENT ON PULSE WAVE VELOCITY IN HYPERTENSIVE PATIENTS ArticleTroitskaya E.A., Kotovskaya J.V., Kobalava Z.D.Arterial Hypertension. Vol. 20. 2014. P.. 578-590
АЛКОГОЛЬНАЯ БОЛЕЗНЬ MonographMoiseev V.S., Garmash I.V., Ogurtsov P.P., Kobalava Zh.D., Shelepin A.A.Общество с ограниченной ответственностью Издательская группа ГЭОТАР-Медиа. 2014. 480 p..
MECHANICAL DYSSYNCHRONY IN PATIENTS WITH CHRONIC HEART FAILURE: CLASSIFICATION, EVALUATION METHODS, SIGNIFICANCE IN SELECTION OF PATIENTS FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT) ArticleСтавцева Ю.В., Виллевальде С.В., Кобалава Ж.Д.Журнал сердечная недостаточность. Vol. 15. 2014. P.. 101-109
PILOT STUDY OF THE PROGNOSTIC SIGNIFICANCE FOR INTERVISIT VARIABILITYOF CLINICAL BLOOD PRESSURE IN PATIENTS WITH LOW EJECTION FRACTION CHRONIC HEART FAILURE ArticleТроицкая Е.А., Котовская Ю.В., Бабаева Л.А., Кобалава Ж.Д.Журнал сердечная недостаточность. Vol. 15. 2014. P.. 361-368
A POSSIBILITY TO INTERCHANGE HEART RATE-SLOWING THERAPY WITH IVABRADINE AND ATENOLOL IN PATIENTS WITH STABLE ANGINA PECTORIS ArticleShavarov A.A., Kiyakbaev G.K., Kobalava Zh.D.Terapevticheskii Arkhiv. Vol. 85. 2013. P.. 77-83
EUROPEAN GUIDELINES ON HYPERTENSION IN 2013: UNCHANGING, NEW, UNSOLVED ArticleKobalava Zh.D., Kotovskaya Yu.V.Kardiologiia. Vol. 53. 2013. P.. 83-95
RADIOFREQUENCY SYMPATHETIC RENAL DENERVATION: A NEW VERSION OF THE OLD METHOD OF TREATMENT RESISTANT HYPERTENSION ArticleShavarov A.A., Mayskov V.V., Kobalava Zh.D.Kardiologiia. Vol. 53. 2013. P.. 72-78
EFFECTS OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF EVEROLIMUS: A SINGLE-DOSE, OPEN-LABEL, PARALLEL-GROUP STUDY ArticlePeveling-Oberhag J., Zeuzem S., Yong W.P., Kunz T., Paquet T., Bouillaud E., Urva S., Anak O., Sellami D., Kobalava Z.Clinical Therapeutics. Vol. 35. 2013. P.. 215-225
NO EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF SERELAXIN, A RECOMBINANT HUMAN RELAXIN-2 IN DEVELOPMENT FOR THE TREATMENT OF ACUTE HEART FAILURE ArticleKobalava Z., Halabi A., Zahringer A., Pang Y., Dahlke M.Circulation. Vol. 128. 2013.
IVABRADIN TREATMENT IN PATIENTS WITH ACUTE CORONARY SYNDROME ArticleShavarov A.A., Kiyakbayev G.K., Moiseyev V.S., Kobalava Z.D.European Heart Journal. Vol. 34. 2013. P.. 413-414
SHORT-TERM TREATMENT WITH LCZ696 IN PATIENTS WITH STABLE CHRONIC HEART FAILURE: EFFECT ON BIOMARKERS ArticleKobalava Z., Jordaan P., Kotovskaya Y., Albrecht D., Chandra P., Alexandriya L., Meray I., Moiseev V.European Heart Journal. Vol. 34. 2013. P.. 1066-1066
BLOOD PRESSURE LOWERING AND NATRIURETIC EFFECTS OF LCZ696 IN PATENTS WITH HYPERTENSION: A RANDOMIZED, DOUBLE-BLIND, CONTROLLED, CROSSOVER STUDY ArticleKobalava Z., Kotovskaya Y., Villevalde S., Moiseev V., Albrecht D., Chandra P., Casagrande L.JOURNAL OF CLINICAL HYPERTENSION. Vol. 15. 2013.
URINE NGAL PREDICTS POOR SHORT-TIME OUTCOMES IN PATIENTS WITH ACUTE KIDNEY INJURY AND DECOMPENSATED HEART FAILURE ArticleKlimenko A., Villevalde S., Efremovtseva M., Kobalava Z.NEPHROLOGY DIALYSIS TRANSPLANTATION. Vol. 28. 2013. P.. 335-335